The history of Viagra presents a complex picture for investors. While the initial introduction generated substantial profits, the end of its intellectual property protection opened the floodgates to cheaper competitors, dramatically eroding sales. This presents a specific dilemma for firms relying on comparable blockbuster products, suggesting that

The legacy of Viagra, and its developer copyright, presents a challenging case study for investors. Originally a blockbuster drug, yielding billions in income, its exclusivity period created a deluge of lower-priced alternatives , significantly impacting its market share . While certain businesses may try to capitalize on similar conditions , the c